Subject: GTX Corp Announces Rapid Result Covid-19 Tests Now Available For Purchase (EUA)

For the identification of the SARS-CoV-2 nucleocapsid protein antigen detectable in nasopharyngeal swab specimen.
 
 

Rapid Diagnostic Test for the SARS-CoV-2 Antigen

 

(Yes, EUA Approved Covid Infection Rapid Tests)

 
 
 

Results are for the identification of the SARS-CoV-2 nucleocapsid protein antigen. The antigen is generally detectable in nasopharyngeal swab specimens during the acute phase of infection. Test results are interpreted at 10 minutes. The presence of two colored lines in the control line region “C” and test line region “T” indicates COVID-19 positive. This test is authorized for use at the Point of Care.

 
BUY 20 TEST PACK NOW ($50 EACH)
 
OR CONTACT US FOR QUOTE
 
 
 

Test results are interpreted at 10 minutes. The presence of two colored lines in the control line region “C” and test line region “T” indicates COVID-19 positive. The presence of one colored lines in the control line region “C” indicates COVID-19 negative. No appearance of a colored line in the control region “C” indicates an invalid test.

 



#gttxmask #smartproducts #nfc #PPE #health #safety #healthcare #veritap #kn95 #assettracking #coronavirus #face mask #covid19 #gtxo


GTX Press       GTX Facebook       GTX Telegram       GTX YouTube

GTX Twitter            LinkedIn       GTX Pinterest         GTX Instagram

 
 
117 W. 9th Street, # 1214, Los Angeles, CA 90015, United States

You may unsubscribe or change your contact details at any time.

    This is an online snapshot of a newsletter created by the owner of gtxmainlist (MetAlert Inc., 117 W. 9th Street, # 1214, 90015 Los Angeles) and sent via GetResponse on 2021-02-08. Report abuse